AlivaMab Discovery Services is a leader in the discovery of antibody therapeutics, trusted by top-tier pharmaceutical and biotechnology companies to deliver panels of drug-quality human antibodies. We meet our partners' design goals, from simple to extraordinarily challenging, through rapid generation of large, molecularly diverse panels of antibodies with deep functional and kinetic characterization, developability assessment and state of the art engineering approaches. Combining collaborative access to our scientists' creativity and experience with the use of trusted, proven technologies, AlivaMab Discovery Services provides the fastest and most de-risked path through discovery and development.